Literature DB >> 22465673

Functional alterations in endothelial NO, PGI₂ and EDHF pathways in aorta in ApoE/LDLR-/- mice.

Gábor Csányi1, Mariusz Gajda, Magdalena Franczyk-Zarow, Renata Kostogrys, Pawel Gwoźdź, Lukasz Mateuszuk, Magdalena Sternak, Luiza Wojcik, Teresa Zalewska, Michal Walski, Stefan Chlopicki.   

Abstract

Adequate endothelial production of nitric oxide (NO), endothelium-derived hyperpolarizing factor (EDHF), and prostacyclin (PGI₂) is critical to the maintenance of vascular homeostasis. However, it is not clear whether alterations in each of these vasodilatory pathways contribute to the impaired endothelial function in murine atherosclerosis. In the present study, we analyze the alterations in NO-, EDHF- and PGI₂-dependent endothelial function in the thoracic aorta in relation to the development of atherosclerotic plaques in apoE/LDLR⁻/⁻ mice. We found that in the aorta of 2-month-old apoE/LDLR⁻/⁻ mice there was no lipid deposition, subendothelial macrophage accumulation; and matrix metalloproteinase (MMP) activity was low, consistent with the absence of atherosclerotic plaques. Interestingly, at this stage the endothelium was already activated and hypertrophic as evidenced by electron microscopy, while acetylcholine-induced NO-dependent relaxation in the thoracic aorta was impaired, with concomitant upregulation of cyclooxygenase-2 (COX-2)/PGI₂ and EDHF (epoxyeicosatrienoic acids, EETs) pathways. In the aorta of 3-6-month-old apoE/LDLR⁻/⁻ mice, lipid deposition, macrophage accumulation and MMP activity in the intima were gradually increased, while impairment of NO-dependent function and compensatory upregulation of COX-2/PGI₂ and EDHF pathways were more accentuated. These results suggest that impairment of NO-dependent relaxation precedes the development of atherosclerosis in the aorta and early upregulation of COX-2/PGI₂ and EDHF pathways may compensate for the loss of the biological activity of NO.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22465673     DOI: 10.1016/j.prostaglandins.2012.02.002

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  22 in total

1.  Apolipoprotein E favours the blunting by high-fat diet of prostacyclin receptor activation in the mouse aorta.

Authors:  Yanhua Cheng; Paul M Vanhoutte; Susan W S Leung
Journal:  Br J Pharmacol       Date:  2018-07-22       Impact factor: 8.739

Review 2.  Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome.

Authors:  Matej Vicen; Ivone Cristina Igreja Sá; Katarína Tripská; Barbora Vitverová; Iveta Najmanová; Samira Eissazadeh; Stanislav Micuda; Petr Nachtigal
Journal:  Cell Mol Life Sci       Date:  2020-11-13       Impact factor: 9.261

Review 3.  Expecting the holistic regulation from Chinese medicine based on the "solar system" hypothesis of ischemic heart disease.

Authors:  Jing Luo; An-Lu Wang; Hao Xu; Da-Zhuo Shi; Ke-Ji Chen
Journal:  Chin J Integr Med       Date:  2016-10-26       Impact factor: 1.978

4.  Characterisation of Atherogenic Effects of Low Carbohydrate, High Protein Diet (LCHP) in ApoE/LDLR-/- Mice.

Authors:  R B Kostogrys; C Johann; I Czyżyńska; M Franczyk-Żarów; A Drahun; E Maślak; A Jasztal; M Gajda; Ł Mateuszuk; T P Wrobel; M Baranska; I Wybrańska; K Jezkova; P Nachtigal; S Chlopicki
Journal:  J Nutr Health Aging       Date:  2015-08       Impact factor: 4.075

5.  Effects of chronic nitric oxide synthase inhibition on V'O2max and exercise capacity in mice.

Authors:  M Wojewoda; K Przyborowski; B Sitek; A Zakrzewska; L Mateuszuk; J A Zoladz; S Chlopicki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-03       Impact factor: 3.000

6.  Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis.

Authors:  Lixia Zeng; Anna V Mathew; Jaeman Byun; Kevin B Atkins; Frank C Brosius; Subramaniam Pennathur
Journal:  J Biol Chem       Date:  2018-03-26       Impact factor: 5.157

7.  Antiatherosclerotic Effects of 1-Methylnicotinamide in Apolipoprotein E/Low-Density Lipoprotein Receptor-Deficient Mice: A Comparison with Nicotinic Acid.

Authors:  Lukasz Mateuszuk; Agnieszka Jasztal; Edyta Maslak; Marlena Gasior-Glogowska; Malgorzata Baranska; Barbara Sitek; Renata Kostogrys; Agnieszka Zakrzewska; Agnieszka Kij; Maria Walczak; Stefan Chlopicki
Journal:  J Pharmacol Exp Ther       Date:  2015-12-02       Impact factor: 4.030

8.  Breast cancer pulmonary metastasis is increased in mice undertaking spontaneous physical training in the running wheel; a call for revising beneficial effects of exercise on cancer progression.

Authors:  Marta Smeda; Kamil Przyborowski; Bartosz Proniewski; Agnieszka Zakrzewska; Dawid Kaczor; Marta Stojak; Elzbieta Buczek; Zenon Nieckarz; Jerzy A Zoladz; Joanna Wietrzyk; Stefan Chlopicki
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

9.  Hypercholesterolemia increases plasma saturated and n-6 fatty acids altering prostaglandin homeostasis and promotes endothelial dysfunction in rabbits.

Authors:  M Medina; M R Alberto; L Sierra; C Van Nieuwenhove; S Saad; M I Isla; S Jerez
Journal:  Lipids       Date:  2014-06-01       Impact factor: 1.880

10.  Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade.

Authors:  Simbarashe Magwenzi; Casey Woodward; Katie S Wraith; Ahmed Aburima; Zaher Raslan; Huw Jones; Catriona McNeil; Stephen Wheatcroft; Nadira Yuldasheva; Maria Febbriao; Mark Kearney; Khalid M Naseem
Journal:  Blood       Date:  2015-02-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.